Woolcock Institute Of Medical Research
Clinical trials sponsored by Woolcock Institute Of Medical Research, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a sedative quiet the Brain's alarm system in insomnia? Results expected Mar 2027 (estimated)
-
Sleep pill may shield brain from Alzheimer's damage
Disease control Recruiting nowThis study tests whether the insomnia medication lemborexant (Dayvigo) can lower blood markers of brain damage in adults aged 40–65 with insomnia. Twenty participants will take the drug or a placebo for two weeks each, then have their blood tested for proteins linked to Alzheimer…
Phase 2 • Sponsor: Woolcock Institute of Medical Research • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a smartphone app cure insomnia in teens? new trial aims to find out
Symptom relief Recruiting nowThis pilot study tests whether a smartphone app called SleepFix, combined with support from a psychologist, can help young people aged 16-24 with insomnia. The app uses sleep restriction therapy to reset sleep patterns. The trial will check if the approach is practical and accept…
Sponsor: Woolcock Institute of Medical Research • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
Online sleep therapy may ease anxiety too
Symptom relief Recruiting nowThis study tests whether an online, therapist-guided program for insomnia can also reduce anxiety symptoms. 98 adults with both chronic insomnia and anxiety will either start the program immediately or after a delay. The program includes sleep education, behavioural strategies, a…
Sponsor: Woolcock Institute of Medical Research • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Can a sedative quiet the Brain's alarm system in insomnia?
Knowledge-focused Recruiting nowThis pilot study will test whether a drug called dexmedetomidine can reduce activity in a brain region (the locus coeruleus) that may be too active during sleep in people with insomnia. Fifteen adults with insomnia will receive either the drug or a placebo before bed in a crossov…
Phase 2 • Sponsor: Woolcock Institute of Medical Research • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC